FDA tests out ‘real-time' clinical trials; AbbVie closes in on a KRAS biotech [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
Today, a brief rundown of news involving The Food and Drug Administration and AbbVie, as well as updates from Pfizer, Eli Lilly and GSK that you may have missed. The Food and Drug Administration on Tuesday announced steps toward implementing “real-time clinical trials” to help speed up drug development. AstraZeneca and Amgen began two “proof of concept” studies in cancer to test out the initiative, through which they'll report endpoints and safety signals to U.S. regulators as they happen. In a statement, Commissioner Martin Makary said the agency's goal is to reduce the “lag time” that can delay regulatory decisions and eventually run “real-time, continuous trials across all phases of drug development.” — Ben Fidler AbbVie has secured an option to acquire Kestrel Therapeutics , a startup developing a drug aimed at cancer-driving KRAS mutations, at an agreed-upon price. According to Kestrel, AbbVie will support funding of KST-6051 , a drug that just began human testing and is des
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- ACROBiosystems and SeromYx Systems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies [Yahoo! Finance]Yahoo! Finance
- FDA Decisions Put Johnson & Johnson's Growth And Valuation In Focus [Yahoo! Finance]Yahoo! Finance
- Eli Lilly bets on recombinases in $2.25bn Profluent R&D pact [Yahoo! Finance]Yahoo! Finance
- ‘American industry is winning': White House touts factory boom — how investors can ride the reshoring wave [Yahoo! Finance]Yahoo! Finance
- Poolbeg eyes transformative summer with POLB 001 data in prospect [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/14/26 - Beat
JNJ
Sec Filings
- 4/28/26 - Form 8-K
- 4/27/26 - Form 4
- 4/27/26 - Form 4
- JNJ's page on the SEC website